regulatory inspection – Page 36

How Poor Stability Protocol Design Creates Shelf-Life Rejection Risk

Identifying and Addressing Stability Study Design Errors to Mitigate Shelf-Life Rejection Risks In pharmaceutical manufacturing, the integrity of stability studies is crucial to ensuring product safety and efficacy over its…

Why Photostability Studies Fail Despite Following ICH Q1B Exposure Conditions

Troubleshooting Photostability Study Failures in Compliance with ICH Q1B In the pharmaceutical industry, the integrity and efficacy of drug products are crucial, and photostability studies serve as a benchmark for…

Why Photostability Studies Fail Despite Following ICH Q1B Exposure Conditions

Addressing Photostability Study Failures: Recommendations for Compliance and Quality Assurance In the realm of pharmaceutical manufacturing, ensuring the quality and stability of products is paramount. One common challenge that arises…

Stability Study Design Errors That Lead to FDA Questions During Review

Mistakes in Stability Study Design That Trigger FDA Inquiries Stability studies are critical in demonstrating the shelf-life and quality of pharmaceutical products. Errors in designing these studies can lead to…

Stability Study Design Errors That Lead to FDA Questions During Review

Addressing Common Errors in Stability Study Design for FDA Review Stability study design errors can create significant challenges in pharmaceutical manufacturing, particularly when submitted data raises concerns during FDA review.…

Poor oversight of quality assurance systems for third-party manufacturers.

Poor oversight of quality assurance systems for third-party manufacturers. Poor oversight of quality assurance systems for third-party manufacturers. Introduction: In the pharmaceutical industry, maintaining high standards of product quality is…